Clinical Trial Update: Paclitaxel & Cyclophosphamide With or Without Trastuzumab Before Surgery in Treating Previously Untreated Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating paclitaxel and cyclophosphamide with or without trastuzumab before surgery in untreated breast cancer; results were posted in December …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Triple-negative Breast Cancer

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• PACLITAXEL (PACLITAXEL)
• Trastuzumab (trastuzumab)

Snippet

Sponsor: University of Nebraska | Conditions: Estrogen Receptor Negative, Estrogen Receptor Positive | Phase 2 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2023-12-20